Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: Possible pathogenic role in diabetic nephropathy

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 5, 2009, Pages

  Min, Danqing ^a   Lyons, J Guy ^a,b   Bonner, James ^a   Twigg, Stephen M ^a,b   Yue, Dennis K ^a,b   McLennan, Susan V ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cell adhesion and infiltration; Inflammation response; Matrix degradation; Matrix metalloproteinases

Indexed keywords

GELATINASE B; GLUCOSE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; FETUS; HUMAN; HUMAN CELL; MALE; MESANGIUM CELL; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 70350704815     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00074.2009     Document Type: Article

References (29)

1. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250, 1993.
2. Chana RS, Martin J, Rahman EU, Wheeler DC. Monocyte adhesion to mesangial matrix modulates cytokine and metalloproteinase production. Kidney Int 63: 889-898, 2003. (Pubitemid 36315566)
3. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65: 116-128, 2004. (Pubitemid 38037496)
4. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant 19: 2987-2996, 2004. (Pubitemid 40057619)
5. Chow FY, Nikolic-Paterson DJ, Ma FY, Ozols E, Rollins BJ, Tesch GH. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 50: 471-480, 2007.
6. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Rollin BJ, Tesch GH. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 69: 73-80, 2006. (Pubitemid 43117741)
7. Fogo AB. Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol 7: 147-159, 1999.
8. Galkina E, Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 17: 368-377, 2006.
9. Kanamori H, Matsubara T, Mima A, Sumi E, Nagai K, Takahashi T, Abe H, Iehara N, Fukatsu A, Okamoto H, Kita T, Doi T, Arai H. Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochem Biophys Res Commun 360: 772-777, 2007. (Pubitemid 47077388)
10. Kelly DJ, Chanty A, Gow RM, Zhang Y, Gilbert RE. Protein kinase C beta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. J Am Soc Nephrol 16: 1654-1660, 2005. (Pubitemid 41716471)
11. Kiyici S, Erturk E, Budak F, Ersoy C, Tuncel E, Duran C, Oral B, Sigirci D, Imamoglu S. Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy. Arch Med Res 37: 998-1003, 2006. (Pubitemid 44512061)
12. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR, Thompson MM. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31: 40-47, 2000. (Pubitemid 30035750)
13. McLennan S, Yue D, Turtle J. Effect of glucose on matrix metalloproteinase activity in mesangial cells. Nephron 79: 293-298, 1998. (Pubitemid 28310334)
14. McLennan SV, Death AK, Fisher EJ, Williams PF, Yue DK, Turtle JR. The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy. Cell Mol Biol 45: 123-135, 1999.
15. Min D, Lyons JG, Jia J, Lo L, McLennan SV. 2-Methoxy-2,4-diphenyl-3(2H)- furanone-labeled gelatin zymography and reverse zymography: a rapid real-time method for quantification of matrix metalloproteinases-2 and -9 and tissue inhibitors of metalloproteinases. Electrophoresis 27: 357-364, 2006. (Pubitemid 43210501)
16. Min D, Moore AG, Bain MA, Breit SN, Lyons JG. Activation of macrophage promatrix metalloproteinase-9 by lipopolysaccharide-associated proteinases. J Immunol 168: 2449-2455, 2002. (Pubitemid 34171849)
17. Mora C, Navarro JF. The role of inflammation as a pathogenic factor in the development of renal disease in diabetes. Curr Diab Rep 5: 399-401, 2005. (Pubitemid 43020005)
18. Nguyen D, Ping F, Mu W, Hill P, Atkins RC, Chadban SJ. Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) 11: 226-231, 2006. (Pubitemid 43829442)
19. Parks WC, Mecham RP. Matrix Metalloproteinases. San Diego: Academic, 1998.
20. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
21. Ritz E, Rychlik I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34: 795-808, 1999. (Pubitemid 29521694)
22. Shapiro SD, Senior Matrix metalloproteinases RM. Matrix degradation and more. Am J Respir Cell Mol Biol 20: 1100-1102, 1999.
23. Stout LC, Kumar S, Whorton EB. Focal mesangiolysis and the pathogenesis of the Kimmelstiel-Wilson nodule. Hum Pathol 24: 77-89, 1993. (Pubitemid 23046676)
24. Takahashi K, Mizuarai S, Araki H, Mashiko S, Ishihara A, Kanatani A, Itadani H, Kotani H. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 278: 46654-46660, 2003. (Pubitemid 37452242)
25. van der Loos CM, Gobel H. The animal research kit (ARK) can be used in a multistep double staining method for human tissue specimens. J Histochem Cytochem 48: 1431-1438, 2000. (Pubitemid 30737816)
26. Vos C, Gartner S, Ransohoff R, McArthur J, Wahl L, Sjulson L, Hunter E, Conant K. Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration. J Neuroimmunol 109: 221-227, 2000. (Pubitemid 30742326)
27. Wall SJ, Sampson MJ, Levell N, Murphy G. Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts. Br J Dermatol 149: 13-16, 2003. (Pubitemid 36966505)
28. Woessner JF, Nagase H. Matrix Metalloproteinases and TIMPs. Oxford: Oxford University Press, 2000, p. xiii.
29. Woessner JJ. The family of matrix metalloproteinases. Ann NY Acad Sci 732: 11-21, 1994.